Glycaemic Effects of a 156-km Ultra-trail Race in Athletes: An Observational Field Study.
Autor: | Parent, Cassandra, Mauvieux, Benoît, Lespagnol, Elodie, Hingrand, Corentin, Vauthier, Jean-Charles, Noirez, Philippe, Hurdiel, Rémy, Martinet, Quentin, Delaunay, Pierre-Louis, Besnard, Stéphane, Heyman, Joris, Gabel, Virginie, Baron, Pauline, Gamelin, François-Xavier, Maboudou, Patrice, Rabasa-Lhoret, Rémi, Jouffroy, Romain, Heyman, Elsa |
---|---|
Předmět: |
EXERCISE physiology
REPEATED measures design RISK assessment SCALE analysis (Psychology) RESEARCH funding SKELETAL muscle ENDURANCE sports SCIENTIFIC observation LOGISTIC regression analysis INSULIN HYDROCORTISONE LACTATE dehydrogenase WEARABLE technology DESCRIPTIVE statistics EXTREME sports ATHLETES HYPERGLYCEMIA CREATINE kinase CONTINUOUS glucose monitoring FIELD research PSYCHOLOGICAL stress ANAEROBIC exercises ATHLETIC ability FATTY acids INFLAMMATION BODY movement PSYCHOLOGICAL tests DATA analysis software HYPOGLYCEMIA BLOOD sugar monitoring REGRESSION analysis DISEASE risk factors |
Zdroj: | Sports Medicine; Aug2024, Vol. 54 Issue 8, p2169-2184, 16p |
Abstrakt: | Background: Ultra-trail running races pose appreciable physiological challenges, particularly for glucose metabolism. Previous studies that yielded divergent results only measured glycaemia at isolated times. Objectives: We aimed to explore the impact of an ultra-endurance race on continuously measured glycaemia and to understand potential physiological mechanisms, as well as the consequences for performance and behavioural alertness. Methods: Fifty-five athletes (78% men, 43.7 ± 9.6 years) ran a 156-km ultra-trail race (six 26-km laps, total elevation 6000 m). Participants wore a masked continuous glucose monitoring sensor from the day before the race until 10 days post-race. Blood was taken at rest, during refuelling stops after each lap, and after 24-h recovery. Running intensity (% heart rate reserve), performance (lap times), psychological stress, and behavioural alertness were explored. Linear mixed models and logistic regressions were carried out. Results: No higher risk of hypo- or hyperglycaemia was observed during the exercise phases of the race (i.e. excluding stops for scientific measurements and refuelling) compared with resting values. Laps comprising a greater proportion of time spent at maximal aerobic intensity were nevertheless associated with more time > 180 mg/dL (P = 0.021). A major risk of hyperglycaemia appeared during the 48-h post-race period compared with pre-race (P < 0.05), with 31.9% of the participants spending time with values > 180 mg/dL during recovery versus 5.5% during resting. Changes in circulating insulin, cortisol, and free fatty acids followed profiles comparable with those usually observed during traditional aerobic exercise. However, creatine phosphokinase, and to a lesser extent lactate dehydrogenase, increased exponentially during the race (P < 0.001) and remained high at 24-h post-race (P < 0.001; respectively 43.6 and 1.8 times higher vs. resting). Glycaemic metrics did not influence physical performance or behavioural alertness. Conclusion: Ultra-endurance athletes were exposed to hyperglycaemia during the 48-h post-race period, possibly linked to muscle damage and inflammation. Strategies to mitigate muscle damage or subsequent inflammation before or after ultra-trail races could limit recovery hyperglycaemia and hence its related adverse health consequences. Trial Registration Number: NCT05538442 2022–09-21 retrospectively registered. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |